Ascentage Pharma Group International
AAPG ✗ NOT COMPLIANTFree checks used up today ☆ Track — members
NASDAQ
·
Healthcare
·
Biotechnology & Medical Research
·
Last Close
$15.06
▼ -0.07%
Price charts are for members
Interactive price history from intraday to 5 years, on every stock and ETF.
See plans
Key Metrics
P/E Ratio
N/A
FWD: N/A
Market Cap
$1.38B
Small Cap
Div Yield
N/A
N/A
EPS Growth
+62.01%
YoY
RSI (14)
47.76
Momentum
Beta
N/A
vs Market
52W High
$34.30
56.09% below
52W Low
$13.49
11.68% above
Volume
549
Avg 1.87K
P/B
12.93
Price-to-book
ROE
-156.46%
Return on equity
Free Float
100.00%
Public shares
Historical Returns
5D
+2.38%
1M
+4.15%
3M
-11.36%
6M
-31.58%
YTD
-42.50%
1Y
-54.24%
3Y
N/A
5Y
N/A
Financials & Valuation
TTM · Annual
| Total Revenue | $82.10M |
| Net Income | $-177,744,777.00 |
| Revenue Growth (YoY) | +29.32% |
| Gross Margin | 91.48% |
| Operating Margin | -213.99% |
| Net Profit Margin | -216.50% |
| ROE | -156.46% |
| ROA · ROIC | N/A · N/A |
| P/E Ratio | N/A |
| Forward P/E (FY1) | N/A |
| PEG Ratio | N/A |
| P/S | 28.46 |
| P/B | 12.93 |
| P/FCF | N/A |
| EPS Growth | +62.01% |
| Outstanding Shares | 374.96M |
Technical Indicators
| 50-Day SMA | $15.64 |
| 200-Day SMA | $19.88 |
| RSI (14) | 47.76 |
| Beta | N/A |
| 52-Week High | $34.30 |
| 52-Week Low | $13.49 |
| Volume Today | 549 |
| Avg Daily Volume (30D) | 1.87K |
| Relative Volume | 0.29x |
| Volatility (10D) | 65.23 |
| Volatility (30D) | 74.01 |
| Free Float | 100.00% |
